Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

HYTN Innovations Inc. (C:HYTN)

Business Focus: Non-Alcoholic Beverages (NEC)

Feb 20, 2024 08:55 am ET
HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot
HYTN Innovations Inc. (CSE: HYTN "HYTN or The Company"), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“Nano Shot”) to...
Feb 09, 2024 08:00 am ET
HYTN Announces Non-Brokered Private Placement for up to C$1 Million
HYTN Innovations Inc. (the “Company” or “HYTN”) (CSE: HYTN) is pleased to announce a non-brokered private placement of up to 13,333,334 units of the Company (“Units”) at a price of $0.075 per Unit (the “Offering”), for aggregate gross proceeds of...
Oct 26, 2023 08:00 am ET
HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption
HYTN Innovations Inc. (the “Company” or “HYTN”) (CSE: HYTN) is pleased to announce that it has closed its previously announced non-brokered private placement of units of the Company (“Units”) by issuing a total of 5,050,000 Units at a price of...
Mar 02, 2023 08:00 am ET
HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today that it has submitted an amendment to its Controlled Drugs and...
Feb 23, 2023 08:40 am ET
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances...
Feb 16, 2023 08:54 am ET
HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leading manufacturer of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to provide an update on its Active...
Nov 30, 2022 08:00 am ET
HYTN Sells Out of Innovative Holiday Products
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has achieved 100% purchase fulfillment of its holiday specific offerings, delivering festive flavours to cannabis consumers...
Oct 24, 2022 08:00 am ET
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement (the “Agreement”) with Rose LifeScience Inc....
Oct 17, 2022 08:00 am ET
HYTN Awarded Controlled Drugs and Substances Dealer’s License Allowing for Production and Sale of Psilocybin
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leading cannabis company focused on creating consistent, natural and delicious cannabis products, is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has been...
Sep 29, 2022 08:00 am ET
HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a manufacturing agreement (the “Agreement”) with Tricanna Industries Inc. (“Tricanna”), a...
Aug 29, 2022 08:00 am ET
HYTN Announces Launch of Rapid Onset Nano Gummies and Provides Commercial Update
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that, through its wholly owned subsidiary, HYTN Cannabis Inc., it has successfully developed and listed for sale its all-new Nano Gummies product (the “Nano...
Aug 23, 2022 08:00 am ET
HYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna Facility
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license (the “License”) by Health Canada allowing for the sale of cannabis for medical...
Jun 14, 2022 09:37 am ET
HYTN Secures Cannabis Cultivation License to Elevate the Quality of its Cannabis Inputs
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has received a license amendment (the “License Amendment”) from Health Canada allowing for the cultivation of cannabis. This...
May 31, 2022 08:00 am ET
HYTN Innovations Inc. Reports Q2 Results
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to report certain highlights from its Q2 financial statements (the “Q2 Results”) for the three and six months ended March 31, 2022. The Q2 Results reflect the details of HYTN’s...
May 11, 2022 08:00 am ET
HYTN Accelerates Sales Growth Through Atlantic Canada Distribution
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN, OTC: HYTNF, FRA: 85W0) is pleased to announce that its all-natural, sugar and calorie free, sparkling cannabis beverages are now available for sale in Nova Scotia, expanding the brand’s...
Mar 30, 2022 09:00 am ET
HYTN Grows Exports with Cannabis Flower Sales to Australia
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that it has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand (“Promethean”) pursuant to the...
Mar 17, 2022 08:00 am ET
HYTN Begins Accepting Orders Directly from Provinces and Territories
HYTN Innovations Inc. ("HYTN" or the "Company) (CSE: HYTN) is pleased to announce that it has begun accepting orders directly from Provincial buyers. This news builds on HYTN’s February 22 announcement that it had been awarded approval to sell...
Mar 02, 2022 09:17 am ET
HYTN Reports Q1 Financial Results for the Quarter Ending Dec 31st, 2021
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to report unaudited Q1 financial results (the “Q1 Results”) for its operating subsidiary, HYTN Beverage Corp. (“HYTN Beverage”), for the quarter ended December 31, 2021 (“Q1”)....
Feb 28, 2022 09:00 am ET
HYTN Expands as Cannabis Products Launch in Australia
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that, through a manufacturing and sales agreement (the “Agreement”) with Promethean BioPharma (“Promethean”), it has successfully developed, exported and launched...
Feb 24, 2022 02:30 pm ET
HYTN Innovations Announces Industry Leading Team Serving as Board of Directors
HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to introduce the industry leaders serving on its board of directors (the “Board”). The Board is composed of HYTN founders, Elliot McKerr and Jason Broome, and is strengthened...
Feb 22, 2022 06:41 pm ET
CSE Bulletin: Amended - New Listing - HYTN Innovations Inc. (HYTN)
Toronto, Ontario--(Newsfile Corp. - le 18 février/February 2022) - (This Bulletin has been amended to remove details of a previous consolidation from February 2021.)
Feb 22, 2022 03:00 pm ET
HYTN Innovations Commences Trading on Canadian Securities Exchange under “HYTN”
Innovations Inc. (formerly Mount Dakota Energy Corp.) (CSE: HYTN) (“HYTN” or the “Company”) began trading today on the Canadian Securities Exchange (the “CSE”) under the symbol “HYTN” following its reverse takeover transaction with HYTN Beverage...
Feb 22, 2022 09:00 am ET
HYTN Innovations Awarded Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers
HYTN Innovations Inc. ("HYTN" or the “Company”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license amendment (the “License Amendment”) by Health Canada allowing for the sale of cannabis extract,...
Feb 18, 2022 04:00 pm ET
Mount Dakota Energy Corp. Announces Completion of Business Combinations and Name Change to “HYTN Innovations Inc.”
HYTN Innovations Inc. (formerly, Mount Dakota Energy Corp.) (the “Company”) announces, further to its news releases dated July 12, 2021, February 11, 2022 and February 15, 2022, that it has completed its previously announced acquisition (the...
Feb 18, 2022 02:58 pm ET
CSE Bulletin: New Listing - HYTN Innovations Inc. (HYTN)
Toronto, Ontario--(Newsfile Corp. - le 18 février/February 2022) - The common shares of HYTN Innovations Inc., previously listed as Mount Dakota Energy Corp., have been approved for listing on the CSE.